After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Medical Devices industry segment, falling under the Healthcare sector. The current market capitalization of Beta Bionics Inc is $549.24M. A total of 0.68 million shares were traded on the day, compared to an average of 648.63K shares.
In the most recent transaction, Mensinger Mike bought 33,350 shares of BBNX for 17.00 per share on Jan 31 ’25. After the transaction, the Chief Product Officer now owns 59,019 company shares. In a previous transaction on Jan 31 ’25, Mensinger Mike sold 13 shares at 17.00 per share. BBNX shares that Chief Product Officer owns now total 25,669.
Among the insiders who bought shares, Wellington Hadley Harbor Aggre acquired of 1,000,000 shares on Jan 31 ’25 at a per-share price of $17.00. This resulted in the 10% Owner holding 3,901,599 shares of BBNX after the transaction.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, BBNX has a high of $24.50 and a low of $12.14.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BBNX is Buy with a score of 4.71.
